Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895513 | 1.00 | PDK2 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21895208 | 0.99 | PDK2 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL22388418 | 0.98 | PDK2 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21895244 | 0.98 | PDK2 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21895077 | 0.98 | PDK2 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL23638666 | 0.95 | PDK2 (0.35) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21894843 | 0.94 | PDK2 (0.34) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21894812 | 0.94 | KDM4E (0.35) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21895075 | 0.93 | ESR1 (0.36) | PDK2ESR1ESR2MEN1KMT2A | |
| SCHEMBL21217299 | 0.93 | MEN1 (0.36) | PDK2ESR1ESR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807767-B2 | Ink composition for organic light emitting device | LG CHEM, LTD. | 2023-11-07 | — | — | US | disclosed |
| US-11807767-B2 | Ink composition for organic light emitting device | LG CHEM, LTD. | 2023-11-07 | — | — | US | disclosed |
| US-11702550-B2 | Coating composition, organic light-emitting diode using same, and method for preparing same | LG CHEM, LTD. | 2023-07-18 | — | — | US | disclosed |
| US-11702550-B2 | Coating composition, organic light-emitting diode using same, and method for preparing same | LG CHEM, LTD. | 2023-07-18 | — | — | US | disclosed |
| US-20230043088-A1 | Organic Light Emitting Device | LG CHEM, LTD. (KR) | 2023-02-09 | — | — | US | disclosed |
| US-20210277269-A1 | Ink Composition for Organic Light Emitting Device | LG CHEM, LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
| US-11094887-B2 | Fluorene-based compound, organic light-emitting device using same and method for preparing same | LG CHEM, LTD. | 2021-08-17 | — | — | US | disclosed |
| EP-3789464-A1 | INK COMPOSITION FOR ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-03-10 | — | — | EP | disclosed |
| US-20200277502-A1 | Coating Composition, Organic Light-Emitting Diode Using Same, and Method for Preparing Same | LG CHEM, LTD. (KR) | 2020-09-03 | — | — | US | disclosed |
| WO-2020067800-A1 | INK COMPOSITION FOR ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11094887-B2 | Fluorene-based compound, organic light-emitting device using same and method for preparing same | AFF1, LEF1, FMNL1 | PDK2 3858/4885ESR1 368/4885ESR2 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.